Oncothyreon

Clinical-stage biopharmaceutical company focusing on the development of therapeutic products for the treatment of cancer.

Launch date

1985

Employees

Seattle Washington (HQ)

Date	Investors	Amount	Round
Nov 1991	N/A	N/A	IPO
Sep 2010	Cowen Group Hudson Bay Capital Management Dafna Capital Management Ayer Capital Management Straus Partners Iroquois Capital Heights Capital Management	$14.9m	Post IPO Equity
Apr 2011	Cowen Group Hudson Bay Capital Management Dafna Capital Management Ayer Capital Management Straus Partners Iroquois Capital Heights Capital Management	$40.0m	Post IPO Equity
May 2013	Cowen Group Hudson Bay Capital Management Dafna Capital Management Ayer Capital Management Straus Partners Iroquois Capital Heights Capital Management	$10.0m	Post IPO Equity
Total Funding		-

ACQUISITION by Oncothyreon Aug 2014

Recent News about Oncothyreon